- Home
- NSPR vs NXC Comparison
NSPR vs NXC Comparison
Compare NSPR & NXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- NXC
- Stock Information
- Founded
- NSPR 2005
- NXC 1992
- Country
- NSPR United States
- NXC United States
- Employees
- NSPR N/A
- NXC N/A
- Industry
- NSPR Medical/Dental Instruments
- NXC Investment Managers
- Sector
- NSPR Health Care
- NXC Finance
- Exchange
- NSPR Nasdaq
- NXC Nasdaq
- Market Cap
- NSPR 79.7M
- NXC 79.3M
- IPO Year
- NSPR N/A
- NXC N/A
- Fundamental
- Price
- NSPR $2.36
- NXC $12.97
- Analyst Decision
- NSPR Strong Buy
- NXC
- Analyst Count
- NSPR 2
- NXC 0
- Target Price
- NSPR $4.50
- NXC N/A
- AVG Volume (30 Days)
- NSPR 50.0K
- NXC 17.5K
- Earning Date
- NSPR 05-09-2025
- NXC 01-01-0001
- Dividend Yield
- NSPR N/A
- NXC 3.97%
- EPS Growth
- NSPR N/A
- NXC N/A
- EPS
- NSPR N/A
- NXC 0.19
- Revenue
- NSPR $7,027,000.00
- NXC N/A
- Revenue This Year
- NSPR $28.93
- NXC N/A
- Revenue Next Year
- NSPR $172.18
- NXC N/A
- P/E Ratio
- NSPR N/A
- NXC $70.47
- Revenue Growth
- NSPR 8.49
- NXC N/A
- 52 Week Low
- NSPR $2.07
- NXC $11.86
- 52 Week High
- NSPR $3.80
- NXC $13.70
- Technical
- Relative Strength Index (RSI)
- NSPR 38.53
- NXC 52.48
- Support Level
- NSPR $2.31
- NXC $12.86
- Resistance Level
- NSPR $2.69
- NXC $13.14
- Average True Range (ATR)
- NSPR 0.18
- NXC 0.15
- MACD
- NSPR -0.02
- NXC 0.01
- Stochastic Oscillator
- NSPR 10.42
- NXC 53.66
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing primarily in municipal obligations.